[Must read] Mylander valuation analysis, electrical stimulation products for pelvic and postpartum rehabilitation

Source: Snowball App, Author: Must-read for new students, (https://xueqiu.com/1896346964/226875778)

Disclaimer: The following forecasts are for reference only and cannot be used as a basis for transactions!

Explanation of the forecast table: yellow is the opening price and days predicted by Daxinjun, green is the low-risk range, and red is the high-risk range.In the past few years, according to the statistical data, the correct rate is in the range of 72-78%, and the statistical caliber is ±20% of the opening price.The reasonable, high and low-risk ranges of the Sci-Tech Innovation Board indicate the prices that may be faced in the first five days. The low-risk zone indicates outstanding value, and the high-risk zone is the speculation risk zone.$Mellander(SH688273)$ 

Mellander (688273): The company is mainly engaged in the research and development of pelvic floor and postpartum rehabilitation related products,Production, sales and service, related products mainly include pelvic floor and postpartum rehabilitation equipment, consumables and accessories, information products, etc., which are widely used in obstetrics and gynecology, gynecology, gynecology, pelvic floor rehabilitation centers and confinement centers in medical institutions.Postpartum recovery centers, maternal and child centers and other professional institutions.

Based on years of industry experience in the field of pelvic floor and postpartum rehabilitation, technical accumulation, rich channel resources, and strong organizational construction capabilities, the company actively extends the layout ofsports rehabilitation, female reproductive rehabilitation, nutrition and health management, etc.In the field, has developed products such as finger joint rehabilitation evaluation system, electro-ultrasound therapy instrument, ultrasonic uterine involution instrument, body composition health management analyzer, etc., which will provide new impetus for the company's sustained and rapid growth in the future.

The company's main business

(Source: Company Announcement)

Comparable companies in the same industry:

The company focuses on the fields of women's health and beauty, and conducts product development and technological innovation around common and frequently-occurring diseases in women's entire life cycle.During the reporting period, the company is mainly engaged in the research and development, production, sales and service of related products in the field of pelvic floor and postpartum rehabilitation. Comparable companies in the same industry include Shenzhen Pumen Technologyb>Co., Ltd., NanjingWeiss Medical Technology Co., Ltd., HenanXiangyu MedicalEquipment Equipment Co., Ltd., Guangzhou Longzhijie Technology Technology Co., Ltd., Guangzhou Shanshan Medical Equipment Industry Co., Ltd., etc.

Use of raised funds

Financial Analysis: The company's main business gross profit margins in the past four years are: 79.6%, 80% and 76% and 72.9% respectively.

(Data source: Straight Flush F10)

(Data source: Straight Flush F10)

The company expects to achieve operating income of 178 million to 202 million yuan from January to June 2022, a change of 15.50% to 31.08% over the same period of the previous year; it is expected to achieve a net profit attributable to shareholders of the parent company4,RMB 2.50 million to RMB 51.00 million, a change from -23. 11% to -7.73% over the same period of the previous year; it is expected to realize a net profit of RMB 41.00 million attributable to shareholders of the parent company after deducting non-recurring gains and lossesYuan to 49.500 million yuan, a change of -16.04% to 1.37% compared with the same period of the previous year.

Conclusion:It is estimated that 4,800 yuan will be received in advance for each signing. It is recommended to subscribe carefully, and recommended to pay careful attention in the later stage.

[Note] The degree of attention is divided into: concern, general concern, cautious concern, no concern

Risk warning: The above opinions and information are only some understandings and judgments of this account on the market, and are for reference only. The main text content comes from the company's prospectus.Market risk, the investment need to be cautious.